Latest News for: cd3
Edit
Index-Journal
09 Oct 2026
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026
SHANGHAI and HONG KONG, Oct.
Edit
Sunnyside Daily Sun
08 Oct 2026
Candidates clash over Iran, taxes and more in Washington CD3 debate
(The Center Square) - Republican state Sen. John Braun and Democratic U.S. Rep. Marie Gluesenkamp Perez met in a debate Wednesday night and clashed over the war in Iran, health care, taxes, immigration, election rules and the economy ....
Edit
T–B interactions yield CD3+ B cells and CD20+ T cells with pathogenic features in multiple sclerosis
PNAS 01 Oct 2026
Edit
2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma
PR Newswire 29 Sep 2026
Edit
Montrose Press
22 Sep 2026
Hurd, Romero debate as CD3 race heats up
U.S. House Rep. Jeff Hurd (R-Grand Junction) and Democratic candidate Dwayne Romero got together for what might be their only debate of the election season last Saturday night ... .
Edit
Exhibits Submission for Asset-Backed Securities Offerings (Form ABS-EE) (CD 2017-CD3 Mortgage Trust)
Public Technologies 22 Sep 2026
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington D.C. 20549 ... 333-207132-10 ... CD 2017-CD3 Mortgage Trust ... CD 2017-CD3 Mortgage Trust published this content on September 22, 2026, and is solely responsible for the information contained herein.
Edit
Asset-Backed Issuer Distribution Report (Form 10-D) (CD 2017-CD3 Mortgage Trust)
Public Technologies 22 Sep 2026
). Distribution Date.. 09/14/26. CD 2017-CD3 Mortgage Trust. Determination Date.. 09/08/26 ... 10/13/26 ... Series 2017-CD3 ... 2 ... CD 2017-CD3 Mortgage Trust published this content on September 22, 2026, and is solely responsible for the information contained herein.
Edit
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology (Form 6-K) (Adagene Inc)
Public Technologies 10 Sep 2026
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology.
- 1